Abonnez-vous pour accéder à l'ensemble des données
Entreprise Secteur d'activité Cap. boursière (USDm) # acheteurs nets Valeur nette ($) % du flottant acheté % d'actions détenues par les initiés
Pharmaceuticals & Medical Research Mid (3.1bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (3.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (3.1bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (3.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (3.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.0bn) 0 Aucune activité — 50%+
US CorVel Corp (CRVL)
Healthcare Services Mid (3.0bn) -1–5 -$1M–$10M -0–15% 15–50%
US Heartflow Inc (HTFL)
Healthcare Services Mid (3.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.0bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (3.0bn) 0 Aucune activité — 0–15%
DE MorphoSys AG (MOR)
Pharmaceuticals & Medical Research Mid (3.0bn) 0 Aucune activité — 50%+
US Alumis Inc (ALMS)
Pharmaceuticals & Medical Research Mid (3.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.0bn) 0 Aucune activité — 0–15%
US Covetrus Inc (CVET)
Healthcare Services Mid (2.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.9bn) 0 Aucune activité — 50%+
SE Camurus AB (CAMX)
Pharmaceuticals & Medical Research Mid (2.9bn) 0 Aucune activité — 15–50%
ES Almirall SA (ALM)
Pharmaceuticals & Medical Research Mid (2.9bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (2.9bn) 0 Aucune activité — 15–50%
SE Cellink AB (CLNK-B)
Healthcare Services Mid (2.9bn) 0 Aucune activité — 15–50%
IN Laurus Labs Ltd (LAURUSLABS)
Pharmaceuticals & Medical Research Mid (2.8bn) 0 Aucune activité — 15–50%
Healthcare Services Mid (2.8bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (2.8bn) 0 Aucune activité — 0–15%
US Grail Inc (GRAL)
Pharmaceuticals & Medical Research Mid (2.8bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.8bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (2.8bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (2.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.7bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (2.7bn) 1–5 < $100K 0–15% 50%+
Pharmaceuticals & Medical Research Mid (2.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.7bn) 0 Aucune activité — 0–15%
FR Emeis SA (EMEIS)
Healthcare Services Mid (2.6bn) 1–5 $100K–$1M 0–15% 0–15%
DE Synlab AG (SYAB)
Healthcare Services Mid (2.6bn) 0 Aucune activité — —
Pharmaceuticals & Medical Research Mid (2.6bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (2.6bn) 0 Aucune activité — —
Pharmaceuticals & Medical Research Mid (2.5bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (2.5bn) 0 Aucune activité — 15–50%
Healthcare Services Mid (2.5bn) -1–5 -$100K–$1M -0–15% 0–15%
FR Nanobiotix SA (NANO)
Pharmaceuticals & Medical Research Mid (2.5bn) 0 Aucune activité — 15–50%
Healthcare Services Mid (2.5bn) -1–5 -$10M–$100M -0–15% 0–15%
IN Pfizer Ltd (PFIZER)
Pharmaceuticals & Medical Research Mid (2.5bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (2.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (2.4bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.4bn) 0 Aucune activité — 0–15%
US AxoGen Inc (AXGN)
Healthcare Services Mid (2.4bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.4bn) -1–5 -$100K–$1M -0–15% 0–15%
DK Ambu A/S (AMBU-B)
Healthcare Services Mid (2.4bn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Mid (2.3bn) 0 Aucune activité — 0–15%
IN Dr. Lal PathLabs Ltd (LALPATHLAB)
Healthcare Services Mid (2.3bn) -1–5 -< $100K -0–15% 50%+
US Premier Inc (PINC)
Healthcare Services Mid (2.3bn) 0 Aucune activité — 0–15%
NL Pharvaris NV (PHVS)
Pharmaceuticals & Medical Research Mid (2.3bn) -6–10 -$1M–$10M -0–15% 0–15%
IN Poly Medicure Ltd (POLYMED)
Healthcare Services Mid (2.3bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (2.3bn) -1–5 -< $100K -0–15% 0–15%
IT Amplifon SpA (AMP)
Healthcare Services Mid (2.3bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (2.3bn) 0 Aucune activité — —
Pharmaceuticals & Medical Research Mid (2.3bn) 0 Aucune activité — 15–50%
Healthcare Services Mid (2.3bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.3bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 Aucune activité — 15–50%
US 89Bio Inc (ETNB)
Pharmaceuticals & Medical Research Mid (2.2bn) 0 Aucune activité — 0–15%
GB Genus PLC (GNS)
Pharmaceuticals & Medical Research Mid (2.2bn) 1–5 < $100K 0–15% 0–15%
US Vericel Corp (VCEL)
Pharmaceuticals & Medical Research Mid (2.2bn) -1–5 -$100K–$1M -0–15% 0–15%
IN Natco Pharma Ltd (NATCOPHARM)
Pharmaceuticals & Medical Research Mid (2.2bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (2.2bn) -1–5 -$100K–$1M -0–15% 0–15%
FR Orpea SA (ORP)
Healthcare Services Mid (2.1bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (2.1bn) -1–5 -$1M–$10M -0–15% 0–15%
BE Fagron NV (FAGR)
Pharmaceuticals & Medical Research Mid (2.1bn) -1–5 -$100K–$1M -0–15% 0–15%
AU Ansell Ltd (ANN)
Healthcare Services Mid (2.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 Aucune activité — 0–15%
US Zymeworks Inc (ZYME)
Pharmaceuticals & Medical Research Mid (2.1bn) 0 Aucune activité — 0–15%
US NuVasive Inc (NUVA)
Healthcare Services Mid (2.1bn) 0 Aucune activité — 0–15%
CH BB Biotech AG (BION)
Pharmaceuticals & Medical Research Mid (2.1bn) 0 Aucune activité — 0–15%
US Immunome Inc (IMNM)
Pharmaceuticals & Medical Research Mid (2.1bn) 0 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 1–5 $10M–$100M 0–15% 15–50%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 Aucune activité — 0–15%
US Progyny Inc (PGNY)
Healthcare Services Mid (2.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.0bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (2.0bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (2.0bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (2.0bn) 0 Aucune activité — 0–15%
IN Jubilant Pharmova Ltd (JUBLPHARMA)
Pharmaceuticals & Medical Research Mid (2.0bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (2.0bn) -1–5 -< $100K -0–15% 0–15%
US Zai Lab Ltd (9688)
Pharmaceuticals & Medical Research Small (2.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 0 Aucune activité — 0–15%
Healthcare Services Small (2.0bn) 0 Aucune activité — 15–50%
Healthcare Services Small (2.0bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Small (2.0bn) -1–5 -$100K–$1M -0–15% 0–15%
US Quidel Corp (QDEL)
Healthcare Services Small (2.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.9bn) 0 Aucune activité — 15–50%
US Precigen Inc (PGEN)
Pharmaceuticals & Medical Research Small (1.9bn) -6–10 -$10M–$100M -0–15% 0–15%
US Omnicell Inc (OMCL)
Healthcare Services Small (1.9bn) 0 Aucune activité — 0–15%